Fibromyalgia Treatment Market, (By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe,
Fibromyalgia Treatment Market, (By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Fibromyalgia is a disorder characterized by chronic widespread pain and tenderness in the muscles, ligaments and tendons. It is often accompanied by fatigue, sleep issues, memory and mood issues. The exact cause of fibromyalgia is still unknown but is believed to be due to neurochemical imbalance in the brain. The symptoms negatively impact quality of life of those suffering from it. Currently there is no cure for fibromyalgia but the treatment aims to manage symptoms and improve day to day functioning. Some of the common treatment options include medications, lifestyle changes, alternate therapies, cognitive behavior therapy etc. The global fibromyalgia treatment market is expected to witness significant growth due to the increasing diagnosis rates and growing awareness about the condition.
Market Dynamics:
The global fibromyalgia treatment market is driven by the rising prevalence of fibromyalgia worldwide. As per estimates, fibromyalgia affects about 2-8% of the global population. Moreover, increasing approval of new drug formulations for fibromyalgia treatment is also boosting the market growth. However, high cost of treatment therapies and lack of cure hinders the market potential. Lack of awareness among physicians also poses a challenge. The market players have opportunities to develop novel drug formulations for fibromyalgia cure and offer treatment options at affordable prices. Increasing adoption of biologics also opens new growth avenues.
Key Features of the Study:
This report provides in-depth analysis of the global fibromyalgia treatment market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global fibromyalgia treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study includes Eli Lilly and Company, Pfizer Inc., Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd., Aptinyx Inc., Prismic Pharmaceuticals Inc., Innovative Med Concepts Inc., Intec Pharma Ltd., Astellas Pharma Inc., Johnson & Johnson, GSK, AstraZeneca plc, Bristol Myers Squibb, Viatris, Takeda Pharmaceutical Company Limited, Amgen Inc., and Sanofi.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global fibromyalgia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global fibromyalgia treatment market.
Market Segmentation
Drug Class:
Antidepressants
Antiepileptics
Muscle Relaxants
Analgesics
Others
Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Regional:
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Company Profiles:
Eli Lilly and Company
Pfizer Inc.
Novartis AG
Allergan plc
Sun Pharmaceutical Industries Ltd.
Aptinyx Inc.
Prismic Pharmaceuticals Inc.
Innovative Med Concepts Inc.
Intec Pharma Ltd.
Astellas Pharma Inc.
Johnson & Johnson
GSK
AstraZeneca plc
Bristol Myers Squibb
Viatris
Takeda Pharmaceutical Company Limited
Amgen Inc.
Sanofi
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Drug Class
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Pipeline Analysis
Patent Litigations
Reimbursement
Patent Landscape (ANDA/NDA Intelligence)
PEST Analysis
Porter’s Analysis
4. Global Fibromyalgia Treatment Market- Impact of Coronavirus (COVID-19) Pandemic
Overall Impact
Government Initiatives
COVID-19 Impact on the market
5. Global Fibromyalgia Treatment Market, By Drug Class, 2019 – 2031, (USD BN)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Antidepressants
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Segment Trends
Antiepileptics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Segment Trends
Muscle Relaxants
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Analgesics
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Others
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
6. Global Fibromyalgia Treatment Market, By Distribution Channel, 2019 – 2031, (USD BN)
Overview
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2019 – 2031
Segment Trends
Hospital Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Retail Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
Online Pharmacies
Overview
Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (USD BN)
7. Global Fibromyalgia Treatment Market, By Region, 2019 – 2031, (USD BN)
Introduction
Market Share Analysis, By Region, 2024 and 2031 (%)
Y-o-Y Growth Analysis, For Regions, 2019–2031
Regional Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (USD BN)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD BN)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (USD BN)
North Africa
Central Africa
South Africa
8. Competitive Landscape
Heat Map Analysis
Company Profiles
Eli Lilly and Company
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Market Strategies
Novartis AG
Company Overview
Product Portfolio
Key Developments
Financial Performance
Market Strategies
Allergan plc
Company Overview
Product Portfolio
Key Developments
Financial Performance
Market Strategies
Sun Pharmaceutical Industries Ltd.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Market Strategies
Aptinyx, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Market Strategies
Prismic Pharmaceuticals, Inc.
Company Overview
Product Portfolio
Key Developments
Financial Performance
Market Strategies
Innovative Med Concepts, Inc.
Intec Pharma Ltd
Astellas Pharma Inc.
Johnson & Johnson
GSK
AstraZeneca plc
Bristol Myers Squibb
Viatris
Takeda Pharmaceutical Company Limited
Amgen Inc.
Sanofi
9. Analyst View
Wheel of Fortune
Analyst View
Coherent Opportunity Map
10. References and Research Methodology
References
Research Methodology
About us and Sales Contact
*Browse 32 market data tables and 35 figures on Global Fibromyalgia Treatment Market” - forecast to 2031